Bluejay’s lead product candidate brelovitug (BJT-778) recently received U.S. Food and Drug Administration (FDA) Breakthrough Therapy designation for the treatment of chronic hepatitis delta (CHD).
The "India Loyalty Programs Market Intelligence and Future Growth Dynamics - 50+ KPIs on Loyalty Programs Trends by End-Use ...
Under the terms of the agreement, TG Therapeutics obtains non-exclusive research, clinical and commercial rights to use MaxCyte’s Flow Electroporation ® technology and ExPERTâ„¢ platform. In return, ...
Arbitrator issued interim award and Injunction to prevent future wrongdoing by Prime Therapeutics in antitrust case brought by AIDS Healthcare Foundation Regarding AHF's arbitration victory over ...
BOSTON, Jan. 27, 2025 /PRNewswire/ -- Averna Therapeutics, Inc. ("Averna"; formerly known as Exsilio Therapeutics, Inc.), a biotechnology company developing genomic medicines that insert ...
Javascript is required for you to be able to read premium content. Please enable it in your browser settings.
According to the ethics agreement, Kennedy will also divest his interests in gene editing biotechnology company CRISPR Therapeutics, Amazon, Apple and other companies. The disclosures came on the ...
A period drama set during the reign of King Henry VIII is now streaming on Amazon Prime (Picture: Showtime/ Everett/ Rex/ Shutterstock) Premiering in 2007, The Tudors starred Jonathan Rhys Meyers ...
Max and Starz are joining forces in a new streaming bundle launching on Prime Video in the U.S. The offering will cost $20.99 a month, about 25% less than the price of signing up to each one ...
Prime Target kicks off with a fascinating premise: Edward Brooks (Leo Woodall) is on the brink of unraveling the mathematical secrets that safeguard every computer system in the world. The ...
From a modern perspective, it's also the foundation of so much of our evolving world. In Apple TV+'s Prime Target, a young student's research could revolutionize everything... if a host of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results